SC1-BHC-02-2019
SC1-BHC-02-2019
7 projects · €42,344,686 total EU contribution (project-level) · 100 participating organizations · 20 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€42,344,686
Countries active
Participant organizations by country (headquarters in CORDIS).
- Spain (19)
- Italy (16)
- Germany (14)
- RO (6)
- BE (5)
- Netherlands (5)
- SE (5)
- US (5)
- France (4)
- AT (3)
- NO (3)
- UK (3)
- CH (2)
- DK (2)
- EL (2)
- IL (2)
- CY (1)
- FI (1)
- HU (1)
- LU (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- IDIBAPS-CERCA3 projects · ES
- KI3 projects · SE
- UNIBO2 projects · IT
- CHARITE - UNIVERSITAETSMEDIZIN BERLIN2 projects · DE
- CEA2 projects · FR
- CONCENTRIS RESEARCH MANAGEMENT GMBH2 projects · DE
- HOSPITAL CLINIC DE BARCELONA2 projects · ES
- UB2 projects · ES
- UNIVERSITAIR MEDISCH CENTRUM GRONINGEN1 projects · NL
- ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1 projects · FR
- AZIENDA OSPEDALIERA CITTA DELLA SALUTE E DELLA SCIENZA DI TORINO1 projects · IT
- AOUP1 projects · IT
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Unification of treatments and Interventions for Tinnitus patients UNITI · 848261 | H2020 | €5,989,344 | €0 | Details |
Drug combinations for rewriting trajectories of renal pathologies in type II diabetes (DC-ren) DC-ren · 848011 | H2020 | €5,968,480 | €898,775 | Details |
Effective combinational treatment of chronic pain in individual patients, by an innovative quantitative systems pharmacology pain relief approach. QSPainRelief · 848068 | H2020 | €6,239,539 | €530,000 | Details |
RESISTANCE UNDER COMBINATORIAL TREATMENT IN ER+ AND ER- BREAST CANCER. RESCUER · 847912 | H2020 | €6,000,000 | €103,750 | Details |
taRgeted thErapy for adVanced colorEctal canceR paTients REVERT · 848098 | H2020 | €5,887,274 | €399,420 | Details |
DECISION ON OPTIMAL COMBINATORIAL THERAPIES IN IMIDS USING SYSTEMS APPROACHES DocTIS · 848028 | H2020 | €6,260,050 | €683,201 | Details |
DECOMPENSATED CIRRHOSIS: IDENTIFICATION OF NEW COMBINATORIAL THERAPIES BASED ON SYSTEMS APPROACHES DECISION · 847949 | H2020 | €6,000,000 | €1,305,838 | Details |
